Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
722.9 GBX | +0.68% | +2.97% | +5.68% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 398.6 | 377.5 | 440.5 | 379.3 | 458.8 | 421 |
Enterprise Value (EV) 1 | 447 | 387 | 481 | 434.1 | 552 | 451.5 |
P/E ratio | 6.59 x | -6.45 x | 4.78 x | -7.95 x | 5.49 x | -11.9 x |
Yield | 3.56% | 4.14% | 3.74% | 4.55% | 3.95% | 4.71% |
Capitalization / Revenue | 6.02 x | -7.37 x | 4.52 x | -8.82 x | 5.25 x | -13.7 x |
EV / Revenue | 6.75 x | -7.56 x | 4.93 x | -10.1 x | 6.31 x | -14.7 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | 11.8 x | -10.9 x | 8.48 x | -14.9 x | 11.7 x | -25.2 x |
FCF Yield | 8.47% | -9.21% | 11.8% | -6.73% | 8.57% | -3.98% |
Price to Book | 0.93 x | 1.01 x | 0.98 x | 0.97 x | 0.99 x | 1.01 x |
Nbr of stocks (in thousands) | 54,559 | 56,766 | 56,765 | 58,449 | 59,436 | 60,146 |
Reference price 2 | 7.305 | 6.650 | 7.760 | 6.490 | 7.720 | 7.000 |
Announcement Date | 3/13/18 | 3/14/19 | 3/19/20 | 3/17/21 | 5/6/22 | 5/11/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 66.2 | -51.21 | 97.51 | -43 | 87.42 | -30.72 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | 63.1 | -54.35 | 94.53 | -45.58 | 84.55 | -33.66 |
Operating Margin | 95.31% | 106.13% | 96.95% | 106.02% | 96.71% | 109.56% |
Earnings before Tax (EBT) 1 | 60.48 | -56.92 | 91.91 | -47.39 | 82.86 | -35.25 |
Net income 1 | 60.46 | -56.96 | 91.9 | -47.39 | 82.76 | -35.25 |
Net margin | 91.33% | 111.24% | 94.25% | 110.22% | 94.67% | 114.75% |
EPS 2 | 1.108 | -1.031 | 1.622 | -0.8165 | 1.407 | -0.5883 |
Free Cash Flow 1 | 37.87 | -35.65 | 56.75 | -29.2 | 47.29 | -17.95 |
FCF margin | 57.2% | 69.62% | 58.2% | 67.91% | 54.1% | 58.42% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | 62.63% | - | 61.76% | - | 57.14% | - |
Dividend per Share 2 | 0.2600 | 0.2750 | 0.2900 | 0.2950 | 0.3050 | 0.3300 |
Announcement Date | 3/13/18 | 3/14/19 | 3/19/20 | 3/17/21 | 5/6/22 | 5/11/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 48.4 | 9.51 | 40.5 | 54.7 | 93.1 | 30.4 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 37.9 | -35.7 | 56.8 | -29.2 | 47.3 | -17.9 |
ROE (net income / shareholders' equity) | 14.9% | -14.2% | 22.4% | -11.3% | 19.3% | -8% |
ROA (Net income/ Total Assets) | 8.43% | -7.57% | 13% | -5.8% | 10.2% | -4.11% |
Assets 1 | 716.8 | 752 | 708.8 | 816.7 | 814.2 | 856.8 |
Book Value Per Share 2 | 7.850 | 6.550 | 7.890 | 6.720 | 7.820 | 6.910 |
Cash Flow per Share 2 | 0.3000 | 0.3600 | 0.3400 | 0.4300 | 0.1200 | 0.1600 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 3/13/18 | 3/14/19 | 3/19/20 | 3/17/21 | 5/6/22 | 5/11/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+5.68% | 513M | |
+7.53% | 14.76B | |
+3.43% | 6.24B | |
+10.57% | 4.34B | |
+12.09% | 4.36B | |
-6.14% | 4.07B | |
+6.35% | 3.63B | |
+8.09% | 3.22B | |
+8.38% | 3.08B | |
-2.80% | 2.76B |
- Stock Market
- Equities
- JCH Stock
- Financials JPMorgan Claverhouse Investment Trust plc